Five Watches

Biodata

Feature	Information
Name	Five Watches
Original Name	五更天 (Wǔgēngtiān)
Alias(es)	Wugengtian Group; Wugengtian Pharmaceutical Group; WPG
Affiliation	An Family; five major domestic distributors; seven overseas distributors
Occupation/Role	Pharmaceutical company; botanical-medicine producer; medicinal-herb cultivator; research investor
Leadership	An Wuyang — current CEO; An Huchun — oversees R&D work 684 811
Status	Active 829
First Appearance	Chapter 63

Background / History

Five Watches is a traditional An Family enterprise. Before its later expansion, it was nearly brought down after Tsunamura Pharmaceutical and Caimai Pharmaceutical launched a commercial war that caused it to lose the fifth batch of centralized procurement. 778

Under An Wuyang, Five Watches rapidly expanded its personnel and product capacity. It recruited Taikang Nine Harmony's entire R&D team, including employees photographed entering Five Watches' R&D center. 159 The company later drew public attention for allowing scrutiny of its factory, cafeteria, and employee dormitories. 260

The company developed from a regional pharmaceutical producer into a major pharmaceutical force through its control of medicinal-herb resources and the active ingredients derived from them. It retains a private, family-run structure, does not plan to go public, and does not accept outside investment. Instead, it distributes substantial downstream benefits to preserve its independence and build alliances. 506 682

By the time of its preparatory-class agreements with nine Imperial Capital universities, Five Watches was recognized within the pharmaceutical industry as a newly risen giant, despite the industry's habit of dismissing it as a “bottled-water factory” that transports nature's gifts. 722 825

Products & Core Materials

Product / Material	Description
Energy Recovery Factor	One of Five Watches' two core active-material foundations; used across its flagship product line. 742
Vitality Recovery Factor	The second core active-material foundation; crucial to products including the Lupus Relief Agent and central to the company's botanical-medicine strategy. 413 742
Two Joys	A flagship product associated with the Energy Recovery Factor and Vitality Recovery Factor; its unusual chirality prompted global speculation about Five Watches' technology. 411 413
Comfort Pill	An over-the-counter product distributed as a gift at a Five Watches event and later sold internationally. 267 597
Rescue Heart Pill	A high-demand heart-relief product that outperformed Japan's Human Character Brand Rescue Heart Pills among high-end customers. 682 778
Nourishing Snow repair creams	A skincare line that includes the Nourishing Snow Reverse Time Ultimate Repair Cream. 825 827

Operations

Medicinal-Herb Bases

• Tianjingyan Medicinal Herb Planting Base — One of Five Watches' two principal strategic assets and the original source of its special Forest-Grown Ginseng. 506 545
• Pinecone Forest Farm — Secured by a fifty-year contract running through January 1, 2072; Five Watches intends to establish its second medicinal-herb base there, focused on Forest-Grown Ginseng. 545
• Five Watches' position in botanical medicine rests on controlling rare raw materials rather than publicly demonstrated synthetic-production technology. The company claims it can locate special substances but cannot manufacture the Energy Recovery Factor or Vitality Recovery Factor. 547

Research & Investment

• Five Watches invests in pharmaceutical research, including the Human Immune System Enhancement Project, neurological research, scar-repair research, and IPSC technology. 485 530 572 709
• It established a joint research laboratory in Shengqing with Nova Pharmaceuticals. 359
• It planned a joint IPSC Technology + Two Joys project with Sechenov University, requiring Five Watches to appoint project and financial supervisors and deploy security personnel. 708
• Its work with Johnson Pharmaceuticals requires a laboratory capable of autologous stem-cell culture and personalized customization for a specialized experimental test. 811

Recruitment and Employee Welfare

• Five Watches publicly recruited nationwide for peony-cultivation technical guidance teams, with no age, education, or gender restrictions. 267
• The company permits salary transparency; employees may post their earnings online without a salary-confidentiality clause. 825
• Even long-serving gate security guards can earn more than 10,000 yuan per month, contributing to the company's online reputation for exceptional compensation and benefits. 595 825

Business Model & Distribution

Five Watches maintains its independence by sharing profits with a broad network of distributors rather than concentrating all gains within the An Family. Qin Sheng characterizes the company and its five major domestic distributors as a single business alliance, additionally supported by seven overseas distributors. 506 682

Rescue Heart Pill Batch Allocation	Quantity	Notes
Nova Pharmaceuticals	50,000	Largest allocation under the overseas partnership. 682
Five major domestic distributors	40,000	8,000 pills each. 682
Seven overseas distributors	5,000	Shared allocation. 682
Five Watches	5,000	Retained by the company. 682
Total planned batch	100,000	Planned for production after the New Year. 682

Technology and Public Perception

Mirror Biology Allegations

Musk and other outside observers believe the reversed chirality associated with Two Joys indicates extraordinarily advanced mirror biotechnology. They argue that synthesizing the relevant “left-handed” nucleotides and “right-handed” amino-acid proteins should be beyond Five Watches' visible technical capabilities. 411 412

Five Watches publicly denies possessing such technology. An Wuyang maintains that the special substances are natural phenomena which Five Watches can obtain and locate, rather than materials it can synthesize. 413 547

The suspected implications of the factors—health restoration, youthfulness, and possible life-science applications—have attracted interest from global elite circles and pharmaceutical companies. 413

Industry Reputation

• Pharmaceutical insiders often deride Five Watches as a “bottled-water factory” or a transporter of nature's goods because it primarily extracts and purifies rare natural ingredients. 722 742
• Despite this label, the company is regarded as a new pharmaceutical giant due to its profitability, resource control, and ability to repeatedly develop commercially valuable products. 825
• Five Watches' simple press conferences prioritize announcing core information over elaborate product presentations. 359

Corporate Responsibility

• Two Joys Relief Cooperation Plan — Five Watches proposed a program allowing impoverished families to borrow funds for expensive medicine, with Five Watches guaranteeing the loans, depositing the principal, and assuming 100% of the risk. 343
• Five Watches Love Point — The company continued the program during Spring Festival, distributing warm supplies and New Year's red envelopes to vulnerable regular patrons. 714
• Education Assistance Program — A long-running sponsorship initiative that had operated for twenty-two years and involved more than one thousand recipients; its participant lists are highly classified. 506 826

Security

• Five Watches established the GSS Global Special Security Mobile Unit with a $100 million investment. 359
• Following its second expansion, GSS consisted of eighteen six-person squads, for a total of 108 personnel. 613
• The company also has access to Shadow Shield Security Company, including a branch in White Eagle; GSS has its largest overseas presence there. 829
• Five Watches raised An Wuyang's security arrangements as its global reputation, profits, and resource holdings increased. 607

Relationships

• An Wuyang — CEO and principal decision-maker; directs Five Watches' business strategy, distribution arrangements, partnerships, and public response. 684 682
• An Huchun — An Wuyang's father; manages Five Watches' R&D work and is responsible for technical research. 601 811
• Nova Pharmaceuticals — Overseas agent and joint-research partner; established a Shengqing laboratory with Five Watches and receives major Rescue Heart Pill quotas. 359 682
• Musk — Overseas intermediary, business partner, and persistent investigator of Five Watches' suspected mirror-biotechnology capabilities. 412 413
• Johnson Pharmaceuticals — Partner in the Desert Aloe Project and a specialized experimental program; established a Xia Kingdom branch to deepen cooperation. 572 742 811
• Shengqing Commercial Bank — Cooperates with Five Watches on the Two Joys Relief Cooperation Plan. 343
• Five major domestic distributors — Core domestic distribution alliance; receive quotas and share in Five Watches' downstream profits. 506 682
• Tsunamura Pharmaceutical — Longstanding hostile competitor involved in the commercial conflict that nearly caused Five Watches' collapse. 778
• Radiance Pharmaceuticals — Overseas distributor whose counterfeiters impersonated Five Watches and used confusingly similar names on harmful counterfeit products. 353

Controversies

• Counterfeit Two Joys — Radiance Pharmaceuticals-linked actors sold harmful imitation products under names resembling Two Joys and listed “Night Watchman” or misspelled Five Watches as manufacturers, creating reputational risk for Five Watches. 353
• Foreign regulatory pressure — The Europa Medicines Agency imposed unusually high certification requirements, tariffs, and consumption taxes on Five Watches' product line; Musk warned that the White Eagle FDA could take similar action. 597
• Taebaek Mountains suspicions — Because Five Watches formerly held a monopoly on the Energy Recovery Factor and possesses overseas security capacity, it became a prime suspect in incidents connected to the Taebaek Mountains. 621 829

Trivia

• Five Watches' name is frequently shortened to WPG in chapter titles and business discussions.
• The company has enough public appeal that job seekers openly ask An Wuyang for help joining it. 406
• Five Watches' resource strategy includes deliberately allowing competitors access to special lands in order to weaken its own apparent monopoly and avoid standing out as a lone target. 606